Sentence examples for under clinical study from inspiring English sources

The G. D. Searle pharmaceutical business unit of the Monsanto Corporation has named the Leo Burnett Company in Chicago to handle a new worldwide assignment, the introduction of Celebra, an arthritis therapy now under clinical study.

Very recently, researchers at Sanofi-Aventis developed the novel selective α7 nAChR agonist SSR180711 (4-bromophenyl 1,4-diazabicyclo(3.2.2) nonane-4-carboxylate)(Figure 1) [24], [24], which is under clinical study.

Wee1 is instrumental for the DNA damage G2-to-M checkpoint, and Wee1 inhibitors are currently under clinical study in combination with DNA-damaging drugs in keeping with the idea that pushing DNA-damaged cancer cells into mitosis would help in their killing.

Of note, ONO-4819 is under the clinical study for treating medically refractory ulcerative colitis [ 44], though the result has not been reported.

Direct measurements of arterial pressure were taken under a prospective clinical study conducted at the Critical Care Department and the Post-Anesthesia Care Unit of Vall d'HeBarcelona Spain Hospital in Barcelona (Spain) from January 2010 to March 2012.

Another clinical study under a standard depth of anesthesia and hemodynamic parameters showed similar results [16].

A master's program in education may also include clinical study under the supervision of a licensed counselor, which may be useful if you want to work in a school setting.

Since predicted health and disease states are shown to be sensitive to the initial degree of infection and virulence of the pathogen, the model can be used to define a set of conditions under which clinical studies should be conducted to identify the situations in which probiotic treatment is beneficial and to optimize probiotic administration.

While it is known that good results can be obtained following this PRN treatment regimen under conditions of a controlled clinical study, little is known concerning the PRN results in a clinical setting.

Thus, predictive biomarker tests that are used to balance arms of a study or to select patients for enrollment into a clinical study are under the purview of both the CMS and the U.S. FDA.

(Another large clinical study is already under way).